OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A review on the medicinal chemistry of sodium glucose co-transporter 2 inhibitors (SGLT2-I): Update from 2010 to present
Jonali Ramani, Harshil Shah, Vivek K. Vyas, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100074-100074
Open Access | Times Cited: 7
Jonali Ramani, Harshil Shah, Vivek K. Vyas, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100074-100074
Open Access | Times Cited: 7
Showing 7 citing articles:
COMPUTATIONAL QSAR-BASED MACHINE LEARNING APPROACH FOR PREDICTING ACTIVITY OF SGLT2 INHIBITORS USING THE KNIME PLATFORM
Adha Dastu Illahi, Gatot Fatwanto Hertono, Arry Yanuar
International Journal of Applied Pharmaceutics (2025), pp. 328-333
Open Access
Adha Dastu Illahi, Gatot Fatwanto Hertono, Arry Yanuar
International Journal of Applied Pharmaceutics (2025), pp. 328-333
Open Access
Risk of Diabetic Ketoacidosis Associated with Sodium Glucose Cotransporter-2 Inhibitors: A Network Meta-Analysis and Meta-Regression
Kannan Sridharan, Gowri Sivaramakrishnan
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1748-1748
Open Access | Times Cited: 4
Kannan Sridharan, Gowri Sivaramakrishnan
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1748-1748
Open Access | Times Cited: 4
Exploring novel lead scaffolds for SGLT2 inhibitors: Insights from machine learning and molecular dynamics simulations
Yuandong Yu, Yuting Xia, Guizhao Liang
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130375-130375
Closed Access | Times Cited: 3
Yuandong Yu, Yuting Xia, Guizhao Liang
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130375-130375
Closed Access | Times Cited: 3
Genito-urinary infectious adverse events related to sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression
Kannan Sridharan, Gowri Sivaramakrishnan
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 5-6, pp. 515-524
Closed Access | Times Cited: 3
Kannan Sridharan, Gowri Sivaramakrishnan
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 5-6, pp. 515-524
Closed Access | Times Cited: 3
SGLT2 inhibitors for the treatment of diabetes: a patent review (2019–23)
Rahul Baghel, Nikita Chhikara, Pawan Kumar, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 807-823
Closed Access | Times Cited: 2
Rahul Baghel, Nikita Chhikara, Pawan Kumar, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 807-823
Closed Access | Times Cited: 2
SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus
Nikola Lukić, Mirjana Mačvanin, Zoran Gluvić, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 30, pp. 4781-4806
Closed Access | Times Cited: 5
Nikola Lukić, Mirjana Mačvanin, Zoran Gluvić, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 30, pp. 4781-4806
Closed Access | Times Cited: 5
Bexagliflozin: a comprehensive review of a recently approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus
Ryan L. Bassett, Giovanni Gallo, Kim-Phuong N. Le, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1354-1367
Open Access | Times Cited: 1
Ryan L. Bassett, Giovanni Gallo, Kim-Phuong N. Le, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1354-1367
Open Access | Times Cited: 1
